We are proud to announce our new "Belarus Pharmaceutical & Healthcare Industries Overview 2017" report is ready. The Overview uncovers economic, pharmaceutical and healthcare insights in a tailored made systematic and business styled manner. This report is intended for decision makers, industry professionals, and other stakeholders globally. The report covers a 2016 full year data with the forecast of the economics and pharmaceutical market growth to 2017-2019.

Фармацевтический рынок Украины по итогам августа 2017 года. Макроэкономические индикаторы, новости экономики, компаний и продуктов фармацевтического сектора, новости здравоохранения и регуляторные изменения. Новости рынков стран СНГ.

We are proud to announce our new Kazakhstan Pharmaceutical and Healthcare Industries Overview 2017 is ready. The Overview uncovers economic, pharmaceutical and healthcare insights in a tailored made systematic and business styled manner. This report is intended for decision makers, industry professionals, and other stakeholders globally. The report covers a 2016 full year data with the forecast of the economics and pharmaceutical market growth to 2017-2019

Global medicine spending will reach nearly $1.5 trillion by 2021 on an invoice price basis, up nearly $370 billion from the 2016. We estimate the total pharmaceutical market spending in the CIS region (excl. Russia) will grow up for the same period by +5-7%, from to $7.8 billion in 2016 to $8.3 billion in 2021 or by plus $500 million. Looks tasty. However, pharma and healthcare markets of the CIS region are largely uncharted waters for the rest of the world. UPharma Consulting launching a series of refurbished reports with the aim to uncover the region's opportunities.

Фармацевтический рынок Украины по итогам июля 2017 года. Макроэкономические индикаторы, новости экономики, компаний и продуктов фармацевтического сектора, новости здравоохранения и регуляторные изменения. Новости рынков стран СНГ.